"Authorized" Generics Reduce The Incentive For Patent Challenges, GPhA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
"Authorized" generics reduce the incentive for generic manufacturers to challenge questionable pharmaceutical patents, the Generic Pharmaceutical Association says